IBDEI0CF ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30413,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,30413,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,30414,0)
 ;;=N52.2^^92^1202^46
 ;;^UTILITY(U,$J,358.3,30414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30414,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,30414,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,30414,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,30415,0)
 ;;=N52.03^^92^1202^37
 ;;^UTILITY(U,$J,358.3,30415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30415,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,30415,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,30415,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,30416,0)
 ;;=N52.02^^92^1202^38
 ;;^UTILITY(U,$J,358.3,30416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30416,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,30416,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,30416,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,30417,0)
 ;;=N52.1^^92^1202^45
 ;;^UTILITY(U,$J,358.3,30417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30417,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,30417,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,30417,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,30418,0)
 ;;=N52.01^^92^1202^44
 ;;^UTILITY(U,$J,358.3,30418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30418,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,30418,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,30418,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,30419,0)
 ;;=N95.2^^92^1202^88
 ;;^UTILITY(U,$J,358.3,30419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30419,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,30419,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,30419,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,30420,0)
 ;;=R30.9^^92^1202^69
 ;;^UTILITY(U,$J,358.3,30420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30420,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,30420,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,30420,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,30421,0)
 ;;=R30.0^^92^1202^28
 ;;^UTILITY(U,$J,358.3,30421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30421,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,30421,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,30421,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,30422,0)
 ;;=R33.9^^92^1202^119
 ;;^UTILITY(U,$J,358.3,30422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30422,1,3,0)
 ;;=3^Urine Retention,Unspec
 ;;^UTILITY(U,$J,358.3,30422,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,30422,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,30423,0)
 ;;=R32.^^92^1202^117
 ;;^UTILITY(U,$J,358.3,30423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30423,1,3,0)
 ;;=3^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,30423,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,30423,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,30424,0)
 ;;=N39.41^^92^1202^115
 ;;^UTILITY(U,$J,358.3,30424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30424,1,3,0)
 ;;=3^Urge Incontinence
 ;;^UTILITY(U,$J,358.3,30424,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,30424,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,30425,0)
 ;;=R35.0^^92^1202^67
 ;;^UTILITY(U,$J,358.3,30425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30425,1,3,0)
 ;;=3^Micturition Frequency
 ;;^UTILITY(U,$J,358.3,30425,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,30425,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,30426,0)
 ;;=R35.1^^92^1202^80
 ;;^UTILITY(U,$J,358.3,30426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30426,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,30426,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,30426,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,30427,0)
 ;;=R39.11^^92^1202^68
 ;;^UTILITY(U,$J,358.3,30427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30427,1,3,0)
 ;;=3^Micturition Hesitancy
 ;;^UTILITY(U,$J,358.3,30427,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,30427,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,30428,0)
 ;;=R39.16^^92^1202^105
 ;;^UTILITY(U,$J,358.3,30428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30428,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,30428,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,30428,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,30429,0)
 ;;=R36.0^^92^1202^109
 ;;^UTILITY(U,$J,358.3,30429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30429,1,3,0)
 ;;=3^Urethral Discharge w/o Blood
 ;;^UTILITY(U,$J,358.3,30429,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,30429,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,30430,0)
 ;;=R36.9^^92^1202^110
 ;;^UTILITY(U,$J,358.3,30430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30430,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,30430,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,30430,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,30431,0)
 ;;=R80.1^^92^1202^94
 ;;^UTILITY(U,$J,358.3,30431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30431,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,30431,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,30431,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,30432,0)
 ;;=R80.0^^92^1202^92
 ;;^UTILITY(U,$J,358.3,30432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30432,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,30432,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,30432,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,30433,0)
 ;;=R80.8^^92^1202^95
 ;;^UTILITY(U,$J,358.3,30433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30433,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,30433,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,30433,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,30434,0)
 ;;=R80.3^^92^1202^91
 ;;^UTILITY(U,$J,358.3,30434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30434,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,30434,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,30434,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,30435,0)
 ;;=R80.9^^92^1202^96
 ;;^UTILITY(U,$J,358.3,30435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30435,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,30435,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,30435,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,30436,0)
 ;;=Z87.442^^92^1202^84
 ;;^UTILITY(U,$J,358.3,30436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30436,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,30436,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,30436,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,30437,0)
 ;;=N18.1^^92^1202^15
 ;;^UTILITY(U,$J,358.3,30437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30437,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,30437,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,30437,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,30438,0)
 ;;=N18.2^^92^1202^16
 ;;^UTILITY(U,$J,358.3,30438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30438,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,30438,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,30438,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,30439,0)
 ;;=N18.3^^92^1202^17
 ;;^UTILITY(U,$J,358.3,30439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30439,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,30439,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,30439,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,30440,0)
 ;;=N18.4^^92^1202^18
 ;;^UTILITY(U,$J,358.3,30440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30440,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,30440,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,30440,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,30441,0)
 ;;=N18.5^^92^1202^19
 ;;^UTILITY(U,$J,358.3,30441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30441,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,30441,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,30441,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,30442,0)
 ;;=Q61.3^^92^1202^87
 ;;^UTILITY(U,$J,358.3,30442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30442,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,30442,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,30442,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,30443,0)
 ;;=N20.1^^92^1202^11
 ;;^UTILITY(U,$J,358.3,30443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30443,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,30443,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,30443,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,30444,0)
 ;;=N18.9^^92^1202^20
 ;;^UTILITY(U,$J,358.3,30444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30444,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,30444,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,30444,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,30445,0)
 ;;=N18.6^^92^1202^30
 ;;^UTILITY(U,$J,358.3,30445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30445,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,30445,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,30445,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,30446,0)
 ;;=N52.9^^92^1202^47
 ;;^UTILITY(U,$J,358.3,30446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30446,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,30446,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,30446,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,30447,0)
 ;;=N32.81^^92^1202^82
 ;;^UTILITY(U,$J,358.3,30447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30447,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,30447,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,30447,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,30448,0)
 ;;=Q61.2^^92^1202^86
 ;;^UTILITY(U,$J,358.3,30448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30448,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,30448,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,30448,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,30449,0)
 ;;=N41.1^^92^1202^90
 ;;^UTILITY(U,$J,358.3,30449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30449,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,30449,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,30449,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,30450,0)
 ;;=N11.9^^92^1202^98
 ;;^UTILITY(U,$J,358.3,30450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30450,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,30450,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,30450,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,30451,0)
 ;;=N20.9^^92^1202^116
 ;;^UTILITY(U,$J,358.3,30451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30451,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,30451,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,30451,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,30452,0)
 ;;=R97.20^^92^1202^29
 ;;^UTILITY(U,$J,358.3,30452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30452,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,30452,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,30452,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,30453,0)
 ;;=N52.36^^92^1202^34
 ;;^UTILITY(U,$J,358.3,30453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30453,1,3,0)
 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,30453,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,30453,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,30454,0)
 ;;=N52.37^^92^1202^35
 ;;^UTILITY(U,$J,358.3,30454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30454,1,3,0)
 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
 ;;^UTILITY(U,$J,358.3,30454,1,4,0)
 ;;=4^N52.37
 ;;^UTILITY(U,$J,358.3,30454,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,30455,0)
 ;;=N52.35^^92^1202^36
 ;;^UTILITY(U,$J,358.3,30455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30455,1,3,0)
 ;;=3^Erectile Dysfunction After Radiation Therapy
 ;;^UTILITY(U,$J,358.3,30455,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,30455,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,30456,0)
 ;;=R31.21^^92^1202^56
 ;;^UTILITY(U,$J,358.3,30456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30456,1,3,0)
 ;;=3^Hematuria,Microscopic,Asymptomatic
 ;;^UTILITY(U,$J,358.3,30456,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,30456,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,30457,0)
 ;;=R31.29^^92^1202^57
 ;;^UTILITY(U,$J,358.3,30457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30457,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,30457,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,30457,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,30458,0)
 ;;=R39.198^^92^1202^70
 ;;^UTILITY(U,$J,358.3,30458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30458,1,3,0)
 ;;=3^Micturition,Oth Difficulties
 ;;^UTILITY(U,$J,358.3,30458,1,4,0)
 ;;=4^R39.198
 ;;^UTILITY(U,$J,358.3,30458,2)
 ;;=^5019347
 ;;^UTILITY(U,$J,358.3,30459,0)
 ;;=R39.191^^92^1202^72
 ;;^UTILITY(U,$J,358.3,30459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30459,1,3,0)
 ;;=3^Need to Immediately Re-Void
 ;;^UTILITY(U,$J,358.3,30459,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,30459,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,30460,0)
 ;;=R39.192^^92^1202^71
 ;;^UTILITY(U,$J,358.3,30460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30460,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,30460,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,30460,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,30461,0)
 ;;=R97.21^^92^1202^101
 ;;^UTILITY(U,$J,358.3,30461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30461,1,3,0)
 ;;=3^Rising PSA After Tx for Prostate CA
 ;;^UTILITY(U,$J,358.3,30461,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,30461,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,30462,0)
 ;;=N50.82^^92^1202^102
 ;;^UTILITY(U,$J,358.3,30462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30462,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,30462,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,30462,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,30463,0)
 ;;=N50.812^^92^1202^106
 ;;^UTILITY(U,$J,358.3,30463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30463,1,3,0)
 ;;=3^Testicular Pain,Left Side
 ;;^UTILITY(U,$J,358.3,30463,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,30463,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,30464,0)
 ;;=N50.811^^92^1202^107
 ;;^UTILITY(U,$J,358.3,30464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30464,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,30464,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,30464,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,30465,0)
 ;;=N35.919^^92^1202^112
 ;;^UTILITY(U,$J,358.3,30465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30465,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,30465,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,30465,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,30466,0)
 ;;=N35.92^^92^1202^111
 ;;^UTILITY(U,$J,358.3,30466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30466,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,30466,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,30466,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,30467,0)
 ;;=R82.81^^92^1202^99
 ;;^UTILITY(U,$J,358.3,30467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30467,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,30467,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,30467,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,30468,0)
 ;;=R51.^^92^1203^2
 ;;^UTILITY(U,$J,358.3,30468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30468,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,30468,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,30468,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,30469,0)
 ;;=G44.1^^92^1203^9
 ;;^UTILITY(U,$J,358.3,30469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30469,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,30469,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,30469,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,30470,0)
 ;;=G43.909^^92^1203^5
 ;;^UTILITY(U,$J,358.3,30470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30470,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,30470,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,30470,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,30471,0)
 ;;=G44.009^^92^1203^1
 ;;^UTILITY(U,$J,358.3,30471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30471,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,30471,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,30471,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,30472,0)
 ;;=G44.40^^92^1203^4
 ;;^UTILITY(U,$J,358.3,30472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30472,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,30472,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,30472,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,30473,0)
 ;;=G44.89^^92^1203^3
 ;;^UTILITY(U,$J,358.3,30473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30473,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,30473,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,30473,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,30474,0)
 ;;=G44.84^^92^1203^7
 ;;^UTILITY(U,$J,358.3,30474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30474,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,30474,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,30474,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,30475,0)
 ;;=G44.301^^92^1203^6
 ;;^UTILITY(U,$J,358.3,30475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30475,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,30475,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,30475,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,30476,0)
 ;;=G44.209^^92^1203^8
 ;;^UTILITY(U,$J,358.3,30476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30476,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,30476,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,30476,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,30477,0)
 ;;=I30.0^^92^1204^5
 ;;^UTILITY(U,$J,358.3,30477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30477,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,30477,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,30477,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,30478,0)
 ;;=I34.8^^92^1204^6
 ;;^UTILITY(U,$J,358.3,30478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30478,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,30478,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,30478,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,30479,0)
 ;;=I34.0^^92^1204^13
 ;;^UTILITY(U,$J,358.3,30479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30479,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,30479,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,30479,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,30480,0)
 ;;=I34.9^^92^1204^12
 ;;^UTILITY(U,$J,358.3,30480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30480,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,30480,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,30480,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,30481,0)
 ;;=I34.2^^92^1204^7
 ;;^UTILITY(U,$J,358.3,30481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30481,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,30481,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,30481,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,30482,0)
 ;;=I35.0^^92^1204^10
 ;;^UTILITY(U,$J,358.3,30482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30482,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,30482,1,4,0)
 ;;=4^I35.0
